George D. Yancopoulos
2013
In 2013, George D. Yancopoulos earned a total compensation of $31M as President, Regeneron Laboratories and Chief Scientific Officer at Regeneron Pharmaceuticals, a 62% decrease compared to previous year.
Compensation breakdown
| Bonus | $1,759,500 |
|---|---|
| Option Awards | $28,096,838 |
| Salary | $879,800 |
| Other | $281,455 |
| Total | $31,017,593 |
Yancopoulos received $28.1M in option awards, accounting for 91% of the total pay in 2013.
Yancopoulos also received $1.8M in bonus, $879.8K in salary and $281.5K in other compensation.
Rankings
In 2013, George D. Yancopoulos' compensation ranked 31st out of 12,286 executives tracked by ExecPay. In other words, Yancopoulos earned more than 99.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 31 out of 12,286 | 100th |
Division Manufacturing | 7 out of 4,623 | 100th |
Major group Chemicals And Allied Products | 4 out of 1,457 | 100th |
Industry group Drugs | 3 out of 1,148 | 100th |
Industry Pharmaceutical Preparations | 3 out of 882 | 100th |
Source: SEC filing on April 26, 2016.
Yancopoulos' colleagues
We found five more compensation records of executives who worked with George D. Yancopoulos at Regeneron Pharmaceuticals in 2013.
2013
Leonard Schleifer
Regeneron Pharmaceuticals
Chief Executive Officer
2013
Neil Stahl
Regeneron Pharmaceuticals
Executive Vice President, Research & Development
2013
Robert Landry
Regeneron Pharmaceuticals
Chief Financial Officer
2013
Robert Terifay
Regeneron Pharmaceuticals
Executive Vice President, Commercial
2013
Murray Goldberg
Regeneron Pharmaceuticals